1351 Harbor Bay Parkway
Alameda , CA 94502
Related Content
June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding ...
June 12, 2026
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026
April 13, 2026 — Penumbra, Inc. announced 90-day results of the landmark STORM-PE randomized controlled trial (RCT) ...
April 13, 2026
Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston ...
January 19, 2026
Dec. 16, 2025 — A new study, published in the American Journal of Cardiology, found that the use of Computer Assisted ...
December 23, 2025
Oct. 27, 2025 – Penumbra, Inc. has announced the results of the STORM-PE randomized controlled trial (RCT), which found ...
October 27, 2025
June 16, 2025 – Penumbra, Inc. recently announced the completion of enrollment in the STORM-PE clinical trial. This ...
June 16, 2025
June 5, 2025 – Penumbra, Inc. has announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ...
June 05, 2025
Penumbra recently launched its Element Vascular Access System, a laser-cut hypotube sheath designed for venous ...
January 30, 2025
Nov. 5, 2024 —Penumbra, Inc. recently announced new data that demonstrate patients with intermediate-risk pulmonary ...
November 07, 2024